BioCina
Pharmaceutical Manufacturing • 
Adelaide, South Australia, Australia • 101-200 Employees
Company overview
| Headquarters | 8 Dalgleish St, Thebarton, South Australia 5031, AU |
| Phone number | +61881508200 |
| Website | |
| NAICS | 3254 |
| Keywords | Process Development, Quality Assurance, Formulation, Gmp Manufacturing, Biologics, Analytical Development, Regulatory Support, Scale Up, Tech Transfer, Purification, Fill-Finish, Cell Banking, Microbial Fermentation, Sterile Manufacturing, Plasmid Dna, Cdmo Services, Minicircle Dna, Lnp Formulation, Mrna Manufacturing, Mcb/Wcb Production |
| Founded | 2020 |
| Employees | 101-200 |
| Socials |
Key Contacts at BioCina
Alex Pomerantz
Sr. Director Business Development
Marlen Yanni
Senior Director Of Business Development
Rik Quaghebeur
Sr. Business Development Director Apac & Eu
Michael Cicio
Board Member - Independent Director
Phillip Elliott
Director
BioCina Email Formats
BioCina uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@biocina.com), used 45.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@biocina.com | 45.5% |
{first initial}{last name} | jdoe@biocina.com | 30.9% |
{first name}{last name} | johndoe@biocina.com | 22.7% |
About BioCina
BioCina is a global end-to-end CDMO delivering exceptional quality, regulatory excellence, and industry-leading on-time, in-full delivery. With deep expertise in small molecules, microbial, pDNA, and mRNA, we offer cell line, process, analytical, and formulation development, plus cGMP clinical and commercial manufacturing. We operate two state-of-the-art facilities in Adelaide and Perth, led by highly experienced SMEs with an average tenure of 10+ years. Our sites are licensed by the Australian TGA and have passed inspections by the US FDA, EMA, and Health Canada. With a proven track record of supplying drug substance and sterile drug product to 98 countries, BioCina proudly serves clients across every major global market. Because we are not a drug developer, our sole focus is on advancing our clients’ products. Australia also offers one of the world’s most generous R&D tax incentives, up to 48.5% cash back, making BioCina an ideal partner for scaling and manufacturing.
BioCina revenue & valuation
| Annual revenue | $14,700,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $46,900,000 |
| Total funding | $3,300,000 |
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
BioCina has 83 employees across 10 departments.
Departments
Number of employees
BioCina Tech Stack
Discover the technologies and tools that power BioCina's digital infrastructure, from frameworks to analytics platforms.
WordPress themes
JavaScript libraries
Page builders
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Security
Blogs
Analytics
United Kingdom
Spain
PolandFrequently asked questions
4.8
40,000 users
